Federation des caisses Desjardins du Quebec’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.8K | Hold |
6,992
| – | – | ﹤0.01% | 1728 |
|
2025
Q1 | $40.2K | Hold |
6,992
| – | – | ﹤0.01% | 1529 |
|
2024
Q4 | $34.9K | Buy |
6,992
+592
| +9% | +$2.95K | ﹤0.01% | 1510 |
|
2024
Q3 | $34.5K | Hold |
6,400
| – | – | ﹤0.01% | 1503 |
|
2024
Q2 | $21.2K | Buy |
6,400
+1,105
| +21% | +$3.66K | ﹤0.01% | 1604 |
|
2024
Q1 | $17.3K | Hold |
5,295
| – | – | ﹤0.01% | 1679 |
|
2023
Q4 | $18.6K | Buy |
5,295
+750
| +17% | +$2.63K | ﹤0.01% | 1596 |
|
2023
Q3 | $30.4K | Sell |
4,545
-6,485
| -59% | -$43.3K | ﹤0.01% | 1453 |
|
2023
Q2 | $92.5K | Hold |
11,030
| – | – | ﹤0.01% | 1174 |
|
2023
Q1 | $110K | Buy |
11,030
+1,100
| +11% | +$10.9K | ﹤0.01% | 1135 |
|
2022
Q4 | $69.1K | Sell |
9,930
-500
| -5% | -$3.48K | ﹤0.01% | 1366 |
|
2022
Q3 | $55.7K | Buy |
10,430
+2,150
| +26% | +$11.5K | ﹤0.01% | 1483 |
|
2022
Q2 | $33K | Buy |
8,280
+1,600
| +24% | +$6.38K | ﹤0.01% | 1626 |
|
2022
Q1 | $29.7K | Sell |
6,680
-4,500
| -40% | -$20K | ﹤0.01% | 1726 |
|
2021
Q4 | $44.7K | Hold |
11,180
| – | – | ﹤0.01% | 1626 |
|
2021
Q3 | $98.2K | Buy |
11,180
+420
| +4% | +$3.69K | ﹤0.01% | 1409 |
|
2021
Q2 | $122K | Sell |
10,760
-5,715
| -35% | -$64.8K | ﹤0.01% | 1358 |
|
2021
Q1 | $196K | Buy |
16,475
+1,350
| +9% | +$16K | ﹤0.01% | 1130 |
|
2020
Q4 | $104K | Buy |
15,125
+2,775
| +22% | +$19K | ﹤0.01% | 1272 |
|
2020
Q3 | $91.5K | Buy |
12,350
+6,500
| +111% | +$48.2K | ﹤0.01% | 1083 |
|
2020
Q2 | $24.4K | Buy |
+5,850
| New | +$24.4K | ﹤0.01% | 1395 |
|